Aktienbewertung
Konkurrenz
| Ticker | Preis | Prognose 1J | Prognose 2J | Börsenwert | Div Yld | Wachstumsrate |
|---|---|---|---|---|---|---|
|
NYSE:LLY
Eli Lilly and
|
737.20 | -45,65% | -23,35% | 654.235,43 | 0,71% | 3,59% |
|
NYSE:JNJ
Johnson & Johnson
|
146.82 | 0% | 0% | 356.431,01 | 3,39% | 3,91% |
|
NYSE:MRK
Merck
|
130.12 | -7,08% | 6,52% | 321.694,58 | 2,35% | -19,03% |
|
NYSE:PFE
Pfizer
|
25.64 | 19,53% | 52,98% | 147.226,07 | 6,61% | -9,31% |
|
NasdaqGS:REGN
Regeneron Pharmaceuticals
|
892.48 | -22,88% | -16,31% | 96.373,98 | 0% | 13,9% |
|
NYSE:BMY
Bristol-Myers Squibb
|
44.64 | 59,34% | 69,53% | 90.596,11 | 5,35% | 13,54% |
|
NYSE:ZTS
Zoetis
|
159.70 | 50,35% | 68,97% | 66.942,77 | 1,09% | 11,57% |
|
NYSE:BAX
Baxter International Inc
|
40.64 | 63,14% | 87,8% | 20.103,93 | 2,89% | -3,14% |
|
NasdaqGS:ALNY
Alnylam Pharmaceuticals Inc
|
147.36 | 0% | 0% | 18.260,95 | 0% | 0% |
|
NasdaqGS:VTRS
Viatris Inc
|
11.78 | 4,85% | 15,35% | 13.360,15 | 4,15% | -8,55% |
|
NasdaqGS:UTHR
United Therapeutics
|
238.26 | -0,15% | 10,33% | 11.196,64 | 0% | 5,22% |
|
NYSE:CTLT
Catalent
|
56.30 | -57,01% | -6,2% | 10.040,45 | 0% | -10,41% |
|
NasdaqGS:CYTK
Cytokinetics
|
62.53 | 0% | 0% | 7.941,36 | 0% | 0% |
|
NasdaqGS:IONS
Ionis Pharmaceuticals
|
41.99 | -.150,35% | -.143,74% | 6.374,47 | 0% | 0% |
|
NasdaqGS:MDGL
Madrigal Pharmaceuticals
|
201.07 | 0% | 0% | 5.006,79 | 0% | 0% |
|
NasdaqGS:BCPC
Balchem
|
139.23 | 2,87% | 12,76% | 4.492,53 | 0,57% | 5,85% |
|
NYSE:PRGO
Perrigo Co PLC
|
32.81 | 48,09% | 73,12% | 4.173,89 | 3,46% | -15,93% |
|
NasdaqGS:NEOG
Neogen
|
12.42 | 150,05% | 256,55% | 2.514,82 | 0% | -1,7% |
|
LSE:INDV
Indivior PLC
|
14.63 | -21,77% | 0,7% | 1.906,97 | 0% | -2,7% |
|
NasdaqCM:CORT
Corcept Therapeutics
|
23.37 | -30,32% | -4,82% | 2.383,06 | 0% | 2,03% |
